| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911666 | Lung Cancer | 2005 | 11 Pages |
Abstract
In conclusion, our meta-analysis shows the efficacy of adjuvant chemotherapy in stages I and II resected NSCLC. More data are needed to confirm such a role for induction chemotherapy. Further trials should separate stage III disease from earlier stages.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Berghmans, M. Paesmans, A.P. Meert, C. Mascaux, P. Lothaire, J.J. Lafitte, J.P. Sculier,